| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |